Stiefel Laboratories Completes $640M Connetics Corporation Acquisition Published: Dec 28, 2006 Palo Alto-based Connetics (NASDAQ: CNCT) develops and sells dermatology drugs. The Hart-Scott-Rodino waiting period in the merger expired Dec. 15. In October, Connetic Related links The Business Journals This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news